SWStonkWhisper
← Back to Intel
Insider ActivityMPLT

Foff Erin Pennock, Chief Medical Officer at MapLight Therapeutics, Inc., sold $55K of MPLT

Last updated Aug 12, 2026

This page documents an SEC Form 4 insider trading disclosure for $MPLT securities filed with the Securities and Exchange Commission. Section 16 of the Securities Exchange Act of 1934 mandates that corporate officers, directors, and beneficial owners of more than 10% of a company's registered equity securities must report their personal trades within two business days of execution. Insider transactions are closely monitored by market participants because insiders possess firsthand knowledge of company operations, financial condition, and near-term prospects. The transaction details below are drawn directly from the SEC EDGAR filing database and reflect the information as reported.

Foff Erin Pennock Chief Medical Officer
MapLight Therapeutics, Inc. · $MPLT
$55K Total Value
2,044 Shares Traded
$26.84 Price / Share
401,946 Shares Owned After
2026-04-17 Filing Date

Transaction Details

InsiderFoff Erin Pennock
TitleChief Medical Officer
CompanyMapLight Therapeutics, Inc.
TickerMPLT
Transaction TypeSale
Transaction Date2026-04-15
Shares Traded2,044
Price Per Share$26.84
Total Value$55K
Filed Date2026-04-17
Accession Number0002021233-26-000006

Ownership Context

Shares Owned After Transaction401,946
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0002021233-26-000006

Other Insider Trades — MPLT

Other Trades by Foff Erin Pennock

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for MPLT — MapLight Therapeutics, Inc. →

Track MPLT insider activity in real time on The Wire →

Get alerts when Foff Erin Pennock files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: August 12, 2026 at 07:38 UTC

Not Financial Advice: This article is for informational and educational purposes only and does not constitute financial advice, investment advice, or a recommendation to buy or sell any security. StonkWhisper aggregates publicly available data from verified regulatory filings and proprietary analysis pipelines. All investment decisions are made solely at your own risk. Guerilla Finance LLC is not a registered investment advisor or broker-dealer. Always consult a qualified financial professional before making investment decisions.

Want real-time data? Access The Wire for live sentiment tracking.